ELIZABETH URBANEK ARTICLES
-
NIHR Centre Creates New IMP Transfer Process With Potential To Scale Across UK10/6/2026
NIHR establishes a governed IMP transfer process between clinical trial sites, creating a potential new approach to managing site-level inventory, demand and clinical supply.
-
Rare Disease Trials: Execution Risks No One Warns You About10/6/2026
Rare disease trials demand a different approach to site selection, forecasting, supply, and patient logistics because every patient counts. Explore what can go wrong.
-
AI In Clinical Supply: From Forecasting To Execution Decisions8/25/2026
AI could shift clinical supply from periodic forecasting to continuous decisions, linking live signals with execution while protecting quality and patient continuity now.
-
When IRT Configuration Decisions Disrupt Clinical Supply8/17/2026
IRT decisions can make or break clinical supply. Craig Mooney explains how configuration, enrollment, inventory, and human oversight shape trial execution.
-
When Clinical Supply Plans Meet Site Reality: Lessons From The Front Line8/11/2026
Clinical supply plans can look perfect on paper but fail at the site. A Moorfields surgeon explains how supply delays, packaging, and workflow gaps affect trials and patients.
-
Building Trust In Clinical Supply Digital Transformation7/30/2026
Digital transformation succeeds when clinical supply teams trust their data, systems, and decisions. Explore how governance and adoption unlock better outcomes.
-
South Africa In Clinical Trial Supply: An Underrecognized Capability7/23/2026
Many sponsors still plan for South Africa using outdated assumptions. Learn how current regulatory, logistics, and supply capabilities support reliable clinical trial execution.
-
Engaging Commercial Supply Chain Professionals Early In Clinical Supply Selection7/2/2026
Supplier decisions made during early clinical development can create hidden commercialization risks. Learn why involving commercial supply chain experts earlier changes outcomes.
-
AI In Clinical Trial Supply Chains6/22/2026
AI is moving into clinical trial supply decisions, but value depends on judgment, assumptions, and system integration, not speed or automation.
-
Clinical Trial Supply Failures Start Before First Patient In6/12/2026
Many trial supply disruptions are set in motion years before enrollment begins. Hedley Rees explains how early decisions shape risk, forecasting, inventory, and execution.
-
Clinical Trial Supply Impact Of ICSR Processing Delays6/11/2026
Safety reporting delays can ripple through RTSM, inventory allocation, and resupply planning, creating hidden risks that disrupt clinical trial supply execution.
-
How The Iran Conflict Threatens Global Clinical Supply Chains6/9/2026
Geopolitical disruption is exposing hidden weaknesses in clinical supply networks, forcing sponsors to rethink inventory, depots, comparators, and trial continuity.
-
Clinical Supply Chain Continuity And Resilience6/4/2026
Clinical supply disruptions can derail trials fast. Learn how sponsors build resilience through smarter forecasting, supplier strategy, and continuity planning.
-
Geopolitical Risk Is Reshaping Clinical Trial Supply Chains5/12/2026
Rising geopolitical risk and fuel volatility are breaking clinical supply assumptions, forcing new strategies to protect trial timelines, patient access, and product integrity.
-
Building Win-Win Partnerships In Clinical Trial Supply3/30/2026
Strong supplier partnerships are the backbone of reliable clinical trial supply, driving speed, flexibility, and better outcomes through trust, transparency, and shared goals.
-
Leading Clinical Trial Supply Teams: Insights And Best Practices3/25/2026
Strong clinical trial supply leadership drives trial success through trust, collaboration, and proactive planning across teams, timelines, and complex global supply challenges.